


















httpPercutaneous transluminal angioplasty results
in improved physical function but not balance
in patients with intermittent claudication
Risha Arun Gohil, MBChB, MRCS,a Katherine A. Mockford, MBChB, MRCS,a
Fayyaz A. Mazari, MBChB, MRCS,a Junaid A. Khan, MBChB, MRCS,a Natalie Van Vanicek, PhD,b
Ian C. Chetter, MBChB, FRCS,a and Patrick A. Coughlin, MBChB, FRCS,a Hull, United Kingdom; and
Sydney, New South Wales, Australia
Objective: The aim of this study was to identify whether revascularization by percutaneous transluminal angioplasty (PTA)
for patients with intermittent claudication improved measures of functional performance including balance.
Methods: A prospective observational study was performed at a single tertiary vascular center. Patients with symptomatic
intermittent claudication (Rutherford grades 1-3) were recruited to the study. Participants were assessed at baseline (pre-
PTA) and then 3, 6, and 12 months post-PTA for markers of (1) lower limb ischemia (treadmill walking distances and
ankle-brachial pressure index), (2) physical function (6-minute walk, Timed Up and Go, and chair stand time), (3)
balance impairment using computerized dynamic posturography with the Sensory Organization Test, and (4) quality of
life (VascuQoL and Short Form Health Survey [SF-36]).
Results: Forty-three participants underwent PTA. Over 12 months, a signiﬁcant improvement was demonstrated in initial
(P[ .04) and maximum treadmill walking distance (P[ .019). Physical functional ability improved across all outcome
measures (P < .02), and some domains of both generic (P < .03) and disease-speciﬁc quality of life (P < .01). No
signiﬁcant improvement in balance was demonstrated by the Sensory Organization Test (P [ .24).
Conclusions: Balance impairment is common in claudicants and does not improve with revascularization. Further
research regarding effective treatment of balance impairment is required in this speciﬁc group of patients. (J Vasc Surg
2013;58:1533-9.)Intermittent claudication is a common condition
affecting over 5% of the population over the age of 65 years.
Patients exhibit limited walking ability, but over recent
years a number of studies have identiﬁed that claudication
is also associated with signiﬁcant impairments in overall
physical function,1 including walking speed,2,3 lower limb
strength,4 and balance.5
There is strong evidence that higher levels of daily
activity in claudicants reduces functional decline and asso-
ciated morbidity/mortality in the mid to long term.6,7
Furthermore, there is increasing evidence that claudicants
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Percutaneous transluminal angioplasty (PTA) is now
a well-recognized treatment option for claudicants with
appropriate disease distribution,9 and with acceptable early-
and midterm results with regards to both walking
distances10 and patient reported quality of life.11,12 Little
data is available on the effect of revascularisation as a whole
and PTA speciﬁcally on more global measures of functional
ability including balance.
This study assessed whether patients undergoing PTA
would demonstrate improved measures of physical func-
tion including balance up to 12 months postintervention.METHODS
This prospective longitudinal study was performed at
a single academic surgical vascular unit of a university
hospital. All participants provided written informed consent
and were recruited in accordance with the Declaration of
Helsinki. Ethical approval of the study was gained from
the Local Research Ethical Committee (07/Q1105/12,
07/Q1105/13, 07/H1305/83).
Patients were identiﬁed at outpatient clinics by
their consultant vascular surgeon, and patients deemed
suitable for PTA (as decided at the departmental multi-
disciplinary team meeting) were subsequently invited to
participate in the study. Data were collected prospectively
at baseline and at 3, 6, and 12 months post-PTA.1533
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Claudication was determined by documented current
symptoms of intermittent claudication with either (1) an
ankle-brachial pressure index (ABPI) of #0.9 or (2) >20
mm Hg drop in ankle pressure postexercise testing, or (3)
documented hemodynamically signiﬁcant atherosclerosis
on radiological imaging (angiogram or duplex ultrasound).
Further patient-speciﬁc inclusion criteria included: (1) living
independently in the local community; (2) not requiring
assistance for general activities of daily living including shop-
ping, cleaning, and self-care; (3) over 50 years of age; (4)
English speaking, and; (5) able to comply with simple study
protocol instructions. Patients were excluded if they: (1)
were unable to safely perform balance testing and to comply
with the study protocol as determined by the referring
consultant or study doctor (for example, coexisting neuro-
logical or limiting cardiorespiratory or other signiﬁcant
medical problems); (2) had signiﬁcant peripheral neurop-
athy (Toronto clinical neuropathy score of >813); (3) had
life-limiting conditions (such as active cancer); (4) had
mobility problems (such as major limb amputations, wheel-
chair use, and hemiplegia), and; (5) suffered with dementia.
Assessments
On enrollment into the study, each patient underwent
the following assessments, which were repeated at 3, 6, and
12 months post-PTA:
Clinical indicators of lower limb ischemia. A
constant load treadmill test (1.6 mph) with a 10-degree
incline was performed for a maximum of 5 minutes. A
pre- and postexercise ABPI was calculated using a hand held
Doppler (Parks Medical Electronics, Inc, Aloha, Ore).
Initial claudication distance (ICD; the distance at which
symptoms of ischemic lower limb muscle pain began) and
maximal walking distance (MWD; the distance at which the
patient could not walk any further) were calculated, and
disease severity determined using the Rutherford grade.14
The 6-minute walk test was performed. Patients were
asked to walk at their usual walking pace continually over
a 20-meter path. They were instructed to cover as much
ground as possible during the 6-minute time period at
a self selected comfortable pace. The maximum walking
distance was recorded to the nearest 5 meters.1,15
Assessment of physical ability. Data were collected
from the usual paced 4-meter walk, the chair stand test,
and semi-tandem/tandem balance tests to derive scores
for the Short Physical Performance Battery (SPPB),
a global measure of lower limb physical function.16
Patients were assigned a score of 0 for each task they
were unable to complete and scores of 1 to 4 were
assigned for the remaining tasks, based upon quartiles of
performance for over 6000 patients in the Established
Populations for the Epidemiologic Study of the Elderly.
Patients’ scores were then added to obtain an overall score
between 0 and 12.17
Furthermore, each patient underwent the Timed Up
and Go (TUG) test. The TUG test is a simple assessmentof falls risk.18 During the TUG test, the patient was
observed and timed as they rose from a standard chair
(seat height 46 cm and arm height of 65 cm), walked 3
meters, turned around, walked back to the chair, and
resumed a seated position. An abnormal result was re-
corded when the time to complete the test was greater
than age-matched healthy controls, speciﬁcally if they
exceeded 9.0 seconds for 60 to 69 year olds, 10.2 seconds
for 70 to 79 year olds, and 12.7 seconds for 80 to 99 year
olds.19
Balance. Computerized dynamic posturography
(CDP) was used to objectively assess a patient’s balance.
The Sensory Organization Test (SOT) was performed
using the EquiTest system (NeuroCom International Inc,
Clackamas, Ore). This system is comprised of a standing
platform with dual force plates that can undergo angular
rotation in the anterior-posterior direction (toes up vs
toes down), termed “sway-referenced support.” Move-
ment of the brightly colored visual surround, equally
capable of movement in the anterior-posterior directions,
was termed “sway-referenced surround.” The SOT has
been described previously,8,20 but brieﬂy, it assesses the
patient’s ability to cope with six different conditions to test
balance during static, dynamic, and sensory conﬂicting
conditions. Each condition was repeated three times, and
the mean data were used. Sensory conﬂicting situations
were created by movement of the visual surround
or standing platform in response to the patients’ sway
(calibrated sway-referencing) either with or without visual
input (eyes open or closed).
Data were collected and analyzed using NeuroCom
International software (NeuroCom System Version 8.1.0,
1996-2006; NeuroCom International Inc) and compared
with healthy controls (who had no symptoms or history
of disequilibrium or motor problems) from the NeuroCom
normative database (NeuroCom International Inc). The
data were stratiﬁed into three age groups: 20 to 59 years,
60 to 69 years, and 70 to 79 years. For any patient over
the age of 79 years, their scores were compared with the
70 to 79 years age group controls due to the absence of
older age data. Scores for SOT that fell outside of those
obtained by 95% of controls were described as abnormal
(ie, those falling below the 5th percentile).
Assessment of patient-reported quality of life
(QOL). All patients completed the generic 36-Item Short
Form Health Survey (SF-36) QOL questionnaire21 and the
disease-speciﬁc QOL, the Kings’ VascuQol question-
naire.22,23 The generic SF-36 has been extensively used
within vascular disease.24-26 The Kings College VascuQoL
is a well-validated QOL tool that measures disease-speciﬁc
QOL for patients with Rutherford grade 1-5 disease.
PTA
All angioplasties were performed or supervised by one
of four consultant interventional radiologists in a dedicated
suite under local anesthesia with a single postintervention
overnight stay. PTA was performed in all patients, and
Fig. Flow chart to demonstrate follow-up. PTA, Percutaneous transluminal angioplasty.
Table I. Patient demographics at baseline for all PTA
patients
Demographics Angioplasty, No. (%)
Number 43
Bilateral symptoms 23 (55)









Ischemic heart disease 20 (47)
Hypertension 29 (67)
On statin therapy 32 (74)
Cerebrovascular disease 9 (21)
Diabetes 7 (16)
Smoker (current/ex) 9 (21)/28 (65)
Osteoarthritis lower limb 18 (42)
PTA, Percutaneous transluminal angioplasty.
Ischemic heart disease was deﬁned as a previous cardiac event (myocardial
infarction, angina, or coronary artery bypass graft), and hypertension was
deﬁned as a systolic blood pressure greater than 140 mm Hg (in diabetics, it
was lowered to 130 mm Hg), or the requirement of antihypertensives.
Cerebrovascular disease was deﬁned as having had a previous stroke,
transient ischemic attack, or previous carotid endarterectomy.
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lesions thought to be at high risk of primary failure or distal
embolization). Each procedure was performed within
a month of the baseline visit.
Statistical analysis
Data sets were analysed using SPSS (SPSS version 19;
IBM, Armonk, NY). An alpha value of P # .05 was used
to determine signiﬁcant differences in the data set. Data
were analyzed on an intention-to-treat basis. Intragroup
analysis was performed using Friedman analysis of variance
for continuous data and c2 test for categorical data.
Sample size calculation
Sample size was calculated based on the composite
equilibrium score from the SOT of the EquiTest System.
Due to a lack of data on which to base a power calculation,
initial pilot data from 19 patients with a mean baseline SOT
score of 60% (standard deviation, 24.8) was used. The
minimum expected clinically signiﬁcant improvement
chosen was a score of 73% (standard deviation, 5.4), which
represented the lowest normal mean score for NeuroCom
healthy controls in the 70 to 79 years age category. The
calculated sample size was n ¼ 29, based on 80% power
to detect this difference in the SOT means (difference of
13) using a paired t-test with a .05 two-tailed signiﬁcance
level. Assuming a 25% drop out rate, the target group
size was 37.
RESULTS
Forty-seven patients underwent PTA, with a median
age of 69 years (interquartile range, 63-76), and 70%
(n ¼ 33) were men. Median height was 169 cm; median
weight was 80 kg, resulting in a median body mass indexof 28. Forty-three patients had a Toronto score between
0 and 7, while four patients had a score of $8; these
four were excluded from further analysis. Of those that
underwent PTA, 15 were lost to follow-up, and one died
over the 12-month follow-up period (Fig). Patient comor-
bidities are shown in Table I.
Table II. Changes in markers of lower limb ischemia and physical function over 12 months post-PTA




Pre-exercise ABPI .80 (.66-.93) .92 (.86-1.03) .86 (.77-1.09) .90 (.83-1.01) <.01
Postexercise ABPI .52 (.31-.76) .77 (.53-.87) .60 (.44-1.00) .69 (.49-.94) .12
Treadmill ICD, m 28.6 (16.1-40.2) 41.0 (35.5-87.5) 55.0 (30.5-123.5) 61.0 (25.1-110.5) .04
Treadmill MWD, m 60.8 (49.0-125.0) 82.0 (65.0-125.5) 86.0 (64.5-215.0) 105.0 (64.0-215.0) .02
6-minute ICD, m 120 (50-135) 200 (120-260) 325 (190-367.5) 220 (120-385) .01
6-minute MWD, m 315 (185-400) 360 (280-440) 380 (340-450) 300 (290-360) .02
SPPB 8 (6-10) 10 (8-12) 10 (8-11) 11 (8-11) <.01
4-meter usual walk, seconds 3.9 (3.6-6.3) 4.1 (3.6-5.1) 3.9 (3.5-4.9) 3.7 (3.3-5.3) .03
4-meter fast walk, seconds 3.3 (2.9-4.1) 3.3 (2.6-4.1) 2.9 (2.7-3.6) 2.9 (2.4-3.8) .04
Mean chair stand time, seconds 17.2 (12.4-20.0) 13.3 (11.4-16.3) 12.7 (10.5-16.3) 13.1 (11.9-19.5) .02
TUG, seconds 10.0 (9.3-13.4) 9.2 (7.9-12.0) 8.4 (7.3-10.9) 8.6 (7.4-11.2) <.01
ABPI, Ankle-brachial pressure index; ICD, initial claudication distance; MWD, maximal walking distance; PTA, percutaneous transluminal angioplasty; SBBP,
short physical performance battery; TUG, timed up and go test.
Data are presented as median and interquartile range values.
Table III. Changes in generic (SF-36) QOL over time post-PTA over 12 months
SF-36 domain Baseline 3 months 6 months 12 months
Friedman analysis
of variance
Physical functioning 35.0 (25.0-50.0) 55.0 (40.0-80.0) 52.5 (37.5-72.5) 60.0 (35.5-80.0) <.01
Role physical 25.0 (0.0-50.0) 50.0 (0.0-100.0) 25.0 (0.0-100.0) 12.5 (0.0-100.0) .03
Bodily pain 41.0 (31.0-51.0) 62.0 (41.0-74.0) 41.0 (31.0-92.0) 52.0 (31.0-62.0) .08
General health 50.0 (40.0-72.0) 57.0 (40.0-72.0) 47.0 (40.0-67.0) 45.0 (35.0-72.0) .34
Vitality 50.0 (30.0-65.0) 60.0 (45.0-75.0) 57.5 (42.5-70.0) 50.0 (43.9-75.0) .03
Role emotional 56.3 (33.3-87.5) 100.0 (33.3-100.0) 96.0 (0.0-100.0) 66.7 (0.0-100.0) .17
Social functioning 75.0 (50.0-88.0) 81.3 (50.0-100.0) 75.0 (50.0-100.0) 62.5 (56.8-87.5) .27
Mental health 70.0 (52.0-100.0) 76.0 (64.0-88.0) 80.0 (56.0-92.0) 74.0 (56.0-84.0) .40
Physical summary score 30.3 (25.3-34.5) 42.6 (28.2-48.9) 33.0 (27.1-49.6) 36.5 (24.5-49.3) .01
Mental summary score 52.3 (41.1-61.2) 53.9 (44.4-60.8) 53.5 (40.5-59.9) 51.4 (43.1-58.2) .62
SF-36, Short Form Health Survey; PTA, percutaneous transluminal angioplasty; QOL, quality of life.
Data are presented as median and interquartile range values.
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Pre-exercise ABPI improved signiﬁcantly over the
12-month time course (P < .01); however, postexercise
ABPI did not (P ¼ .12). All walking distance measures, by
either treadmill (MWD, P ¼ .02; ICD, P ¼ .04) or the
6-minute walk (MWD, P ¼ .01; ICD, P ¼ .01) on the
ﬂat showed a signiﬁcant improvement over time (Table II).
Outcomes of the assessment of physical ability
These improved signiﬁcantly over time as measured by
the SPPB score (P < .01), TUG test (P < .01), and mean
chair stand time (P ¼ .02), in addition to the short 4 meter
normal (P ¼ .03) and fast pace (P ¼ .04) walks (Table II).
QOL
Generic QOL, as measured by the SF-36 (Table III),
showed an improvement in four of the domains; physical
functioning (P < .01), role physical (P ¼ .03), vitality
(P ¼ .03), and physical summary score (P ¼ .01).
Disease-speciﬁc QOL improved signiﬁcantly in all domains
(P < .01) except social (P ¼ .11) over the 12-month period
(Table IV).Balance
Tandem stance time. Both semi- and full-tandem
stance did not alter over the course of the 12-month
period (P ¼ .05 and .41, respectively; Table V).
SOT. At baseline, 27 (63%) of the participants passed
the SOT test when compared with healthy age-matched
controls. The median SOT composite scores improved
signiﬁcantly between baseline and 3 months, but this was
not observed over the 12-month duration (P ¼ .24;
Table V).
There was no signiﬁcant difference between those who
had unilateral or bilateral disease (Table VI) or the distribu-
tion of disease (Table VII) when looking at any time point
and the likelihood of passing the SOT test at any time point.
DISCUSSION
Impaired walking ability is the principal symptom re-
ported by claudicants. Detailed analysis, however, reveals
that impairment in walking ability is only a single factor
contributing to overall physical disability in these patients.
A number of other factors including lower limb strength
and balance are also important factors contributing to
Table IV. Changes in disease-speciﬁc (VascuQol) QOL over time post-PTA over 12 months
VascuQol domain Baseline 3 months 6 months 12 months Friedman analysis of variance
Pain 3.0 (4.6-2.6) 5.0 (3.9-6.1) 5.3 (4.0-6.4) 5.8 (5.1-6.3) <.01
Social 4.5 (3.3-6.3) 6.5 (5.3-7.0) 6.5 (4.3-7.0) 6.0 (5.3-7.0) .11
Activities 3.6 (3.3-4.1) 5.5 (4.5-6.5) 5.6 (3.9-6.6) 5.6 (4.1-6.1) .02
Symptoms 4.8 (3.8-5.6) 5.8 (5.5-6.6) 6.0 (5.1-6.5) 6.3 (5.6-6.8) .01
Emotions 4.4 (3.6-5.4) 6.6 (5.5-6.9) 6.3 (5.4-6.9) 6.6 (5.8-7.0) <.01
Total 4.2 (3.3-4.8) 5.8 (5.2-6.4) 6.1 (4.6-6.4) 6.0 (5.1-6.5) <.01
PTA, Percutaneous transluminal angioplasty; QOL, quality of life.
Data are presented as median and interquartile range values.
Table V. Changes in markers of objective balance post-PTA over 12 months
Baseline 3 months 6 months 12 months P
N (missing) 43 39 (4) 22 (21) 28 (15)
Semi-tandem stance, seconds 30.0 (11.7-30.0) 30.00 (30.00-30.00) 30.00 (30.00-30.00) 30.00 (30.00-30.00) .05a
Full tandem stance, seconds 29.5 (7.6-30.0) 30.0 (15.0-30.0) 30.0 (19.0-30.0) 30.0 (20.4-30.0) .41a
Composite SOT score 65.0 (57.8-70.5) 70.0 (63.0-75.5) 69.5 (57.0-77.0) 68.0 (63.3-74.8) .24a
PTA, Percutaneous transluminal angioplasty; QOL, quality of life; SOT, Sensory Organization Test.
Data are presented as median and interquartile range values.
aFriedman analysis of variance.
Table VI. Distribution of unilateral and bilateral










Bilateral 13/10 14/6 6/3 10/3
Unilateral 14/6 14/5 8/3 10/5
P .5 1.0 1.0 .7
SOT, Sensory Organization Test.
P values for Fisher exact test 2  2 tables shown.
Table VII. Distribution of disease pattern in claudicants










Suprainguinal 7/4 9/2 4/3 6/2
Infrainguinal 7/5 8/4 5/2 6/2
Combined angioplasty 13/7 11/5 5/1 8/4
P .9 .7 .6 .9
SOT, Sensory Organization Test.
P values for likelihood ratios shown.
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Simple assessments of balance, such as the single leg stance
time, show postural impairments in individuals with periph-
eral arterial disease, and are associated with a higher preva-
lence of stumbling, unsteadiness on walking, and history of
previous falls. Poor balance may be due to reduced physical
function secondary to ischemic muscle changes27 or central
cerebral ischemia causing vestibular related symptoms
associated with systemic atherosclerosis.8 Poor balance,
with an incidence approaching 40% in the claudicant
population, is recognized to play an important role in
poor overall physical ability. It is well-recognized that
poor balance is a signiﬁcant risk factor for subsequent falls
risk with its associated physical and socioeconomic conse-
quences. Assessment of routine balance impairment is not
routinely undertaken either in primary care or within the
vascular surgical clinic.
There is a strong association between daily physical
activity and longer term outcomes in both the older popu-
lation in general and in claudicants speciﬁcally.6,7,28 Ourstudy shows that over the 1-year follow up period, angio-
plasty signiﬁcantly improves the clinical indicators of lower
limb ischemia, overall physical ability, and QOL in claudi-
cants with 1-year follow-up. No lasting improvements in
balance (either static or dynamic) were observed, despite
the improvement seen in other markers of physical ability.
Given the observed improvements in pre-exercise ABPI
and physical ability, the etiology of balance impairment
and its full impact on claudication remains as yet unknown.
The lack of improvement in balance when physical ability
does improve following PTA justiﬁes our use of balance
speciﬁc investigations. The CDP is a relatively new method
of assessing balance, having been used predominantly in
patients with vestibular-related conditions and latterly in
amputees. As such, there is still little data available on
patients with other chronic disease states, but given the
increasing age of the overall population, we feel that
CDP will continue to deliver further high quality data on
the causes of poor balance.
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porary, pragmatic vascular practice, recruiting all patients
with claudication undergoing PTA. This is also reﬂected
by the fact that we did not routinely undertake postangio-
plasty duplex scanning to conﬁrm patency but relied on
both symptoms and ankle pressure measurement. Disease
distribution (supra-/infrainguinal disease or uni/bilateral
disease) did not appear to impart a confounding inﬂuence
on the SOT results, although the study was not powered to
speciﬁcally look at these factors. Lastly, the slight diversity
between treadmill and 6-minute walking distances at
12 months is difﬁcult to fully explain. It is likely to be
multifactorial and requires further investigation.
One criticism of the study may be the slightly high drop-
out rate (15 of 43 patients). Indeed, this is higher than
previous claudicant-based trials fromourunit, butmay reﬂect
the slightly older population examined.12 Drop-out is an
inherent problem with longer-term prospective studies.
Despite the drop-out rate, this was factored into our recruit-
ment so as tomeet the requirements of the power calculation.
Supervised exercise is currently recommended as the
ﬁrst line treatment in the UK for claudicants,29 and given
the strong evidence that exercise improves balance in elderly
patients, it is likely to be speciﬁcally beneﬁcial for claudicants
with balance impairment, but further studies are required.
For patients with impaired balance, we would advocate
that the same advice that is recommended for people with
previous falls is employed30; a balance and strength exercise
training regimen that has been evidenced.31 The use of Tai
Chi32 has also been advocated, although we still await level
one evidence for this form of intervention.33 Interestingly,
this study is using CDP as an outcome measure.
Intermittent claudication is a relatively stable disease, and
as such, treatment is presently prescribed only if the walking
impairment affects the patient’s day-to-day QOL. This is re-
ﬂected in the large numbers of claudicants with moderate or
severe disease in our patient cohort. Our study conﬁrms
the success in enhancing walking distances with improve-
ments in both treadmill and corridor walking tests seen up
to up to 12 months. This is mirrored in the physical ability
results, where there was at least a one point improvement
in the median SPPB score at all time points when compared
with baseline. This improvement may be considered as not
“clinically signiﬁcant”; however, the associatedQOLdomain
improvements suggest that this is a meaningful change.
In summary, balance impairment is common in patients
with claudication and shows no signiﬁcant sustained
improvement following PTA. Speciﬁc exercise routines are
beneﬁcial in elderly populations with balance impairment,
and merit further investigation in the claudicant population.
Routine balance assessment may be worthwhile in claudi-
cants prior to any intervention as this may contribute to
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